HOOKIPA Pharma Inc (HOOK)
0.9123
-0.01
(-0.70%)
USD |
NASDAQ |
May 03, 16:00
0.9123
0.00 (0.00%)
After-Hours: 20:00
HOOKIPA Pharma Enterprise Value: -25.07M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | -25.07M |
| May 01, 2024 | -27.02M |
| April 30, 2024 | -28.18M |
| April 29, 2024 | -22.86M |
| April 26, 2024 | -27.58M |
| April 25, 2024 | -36.21M |
| April 24, 2024 | -31.87M |
| April 23, 2024 | -40.28M |
| April 22, 2024 | -46.02M |
| April 19, 2024 | -43.45M |
| April 18, 2024 | -40.29M |
| April 17, 2024 | -40.53M |
| April 16, 2024 | -35.84M |
| April 15, 2024 | -40.77M |
| April 12, 2024 | -38.15M |
| April 11, 2024 | -36.30M |
| April 10, 2024 | -33.86M |
| April 09, 2024 | -32.72M |
| April 08, 2024 | -31.87M |
| April 05, 2024 | -41.44M |
| April 04, 2024 | -42.06M |
| April 03, 2024 | -39.88M |
| April 02, 2024 | -40.77M |
| April 01, 2024 | -44.39M |
| March 28, 2024 | -45.52M |
| Date | Value |
|---|---|
| March 27, 2024 | -44.69M |
| March 26, 2024 | -44.83M |
| March 25, 2024 | -46.45M |
| March 22, 2024 | -45.61M |
| March 21, 2024 | -44.33M |
| March 20, 2024 | -45.43M |
| March 19, 2024 | -43.22M |
| March 18, 2024 | -44.93M |
| March 15, 2024 | -44.83M |
| March 14, 2024 | -47.96M |
| March 13, 2024 | -42.60M |
| March 12, 2024 | -43.25M |
| March 11, 2024 | -37.86M |
| March 08, 2024 | -40.67M |
| March 07, 2024 | -39.10M |
| March 06, 2024 | -38.30M |
| March 05, 2024 | -37.20M |
| March 04, 2024 | -35.93M |
| March 01, 2024 | -39.77M |
| February 29, 2024 | -39.98M |
| February 28, 2024 | -36.82M |
| February 27, 2024 | -48.26M |
| February 26, 2024 | -50.09M |
| February 23, 2024 | -52.64M |
| February 22, 2024 | -51.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-85.79M
Minimum
Sep 25 2023
458.52M
Maximum
May 18 2021
61.37M
Average
41.11M
Median
Enterprise Value Benchmarks
| Absci Corp | 471.93M |
| NovaBay Pharmaceuticals Inc | 2.666M |
| Palatin Technologies Inc | 23.59M |
| iBio Inc | 16.94M |
| Theriva Biologics Inc | -13.05M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.82M |
| Revenue (Quarterly) | 7.407M |
| Total Expenses (Quarterly) | 21.83M |
| EPS Diluted (Quarterly) | -0.22 |
| Profit Margin (Quarterly) | -335.1% |
| Earnings Yield | -96.46% |
| Normalized Earnings Yield | -96.46 |